Proceedings: Pharmacology of the adrenergic mechanism.
D018663:Adrenergic Agents / Q000494:pharmacology*; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006145:Guanethidine / Q000494:pharmacology; D008680:Metaraminol / Q000378:metabolism; D051379:Mice; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012640:Seizures / Q000139:chemically induced; D012701:Serotonin / Q000378:metabolism; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects*; D014439:Tyramine / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D018663:Adrenergic Agents; D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D014443:Tyrosine; D008680:Metaraminol; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine; D014439:Tyramine; D006145:Guanethidine